Skip to main content

Together we are beating cancer

Donate now

Science & Technology

Read the latest in pre-clinical research, drug discovery and new technologies in cancer
Showing 12 out of 1531 results
This entry is part 23 of 23 in the series That Cancer Conversation
Head shots of Dr Lian Ni Lee, Sânziana Foia and Professor Christine Harrison

For International Women's Day 2025, we're celebrating three inspirational women and the contributions they have made to cancer research For International Women's Day 2025, we're celebrating three inspirational women and the contributions they have made to cancer research

by Amy Warnock | In depth | 8 March 2025

8 March 2025

Lung cancer cells seen through a microscope, in shades of purple and green,

Cancer Grand Challenges is offering up to £20m funding to teams that can answer seven of the biggest and most important questions in cancer. Cancer Grand Challenges is offering up to £20m funding to teams that can answer seven of the biggest and most important questions in cancer.

by Tim Gunn | News | 5 March 2025

5 March 2025

The DETERMINE trial team celebrating at the Bionow awards

Since launching in December 2021, the DETERMINE trial has hit many milestones on the way to providing much needed treatment options for people with rare cancers, including treating its 100th patient. On Rare Disease Day, we look back at some of those key achievements. Since launching in December 2021, the DETERMINE trial has hit many milestones on the way to providing much needed treatment options for people with rare cancers, including treating its 100th patient. On Rare Disease Day, we look back at some of those key achievements.

by Tim Bodicoat | In depth | 28 February 2025

28 February 2025

A green beam of light from a radiotherapy machine.

Modern radiotherapy is used to treat more than 140,000 people with cancer in the UK every year. We've brought it a long way since 1896. Here's the full story. Modern radiotherapy is used to treat more than 140,000 people with cancer in the UK every year. We've brought it a long way since 1896. Here's the full story.

by Tim Gunn | In depth | 17 February 2025

17 February 2025

Lab-grown bowel cancer cells seen through a microscope. They are colour-enhanced and appear blue.

A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists.  A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists. 

by Tim Gunn | News | 30 January 2025

30 January 2025

A microscope image showing immune cells in bowel cancer.

A new AI test that looks at immune cells could help people with stage 2 bowel cancer avoid chemotherapy after surgery, cutting side effects. A new AI test that looks at immune cells could help people with stage 2 bowel cancer avoid chemotherapy after surgery, cutting side effects.

by Sadaf Shafaghmotlagh, Tim Gunn | Analysis | 27 January 2025

27 January 2025

Salmonella bacteria (rod-shaped organisms coloured blue) in a bowel cancer tumour (coloured beige). The bacteria looks like it is rushing into a hole in the tumour tissue.

Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once. Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once.

by Tim Gunn, Fiona MacLeod | News | 23 January 2025

23 January 2025

Data centre filled with rows of servers

Today, Cancer Research UK, the National Institute for Health and Care Research (NIHR) and the Engineering and Physical Sciences Research Council (EPSRC) are announcing £10 million to create the Cancer Data-Driven Detection programme, which aims to use data to identify individual cancer risk. Today, Cancer Research UK, the National Institute for Health and Care Research (NIHR) and the Engineering and Physical Sciences Research Council (EPSRC) are announcing £10 million to create the Cancer Data-Driven Detection programme, which aims to use data to identify individual cancer risk.

by Amy Warnock, Graeme Sneddon | News | 22 January 2025

22 January 2025

A concept illustration of the tumour microenvironment

A bold change of approach by our scientists investigating what prevents immunotherapy from working in a large number of patients has led to a significant discovery that could improve outcomes across multiple cancers. A bold change of approach by our scientists investigating what prevents immunotherapy from working in a large number of patients has led to a significant discovery that could improve outcomes across multiple cancers.

by Elisa Mitchell | News | 7 January 2025

7 January 2025